By Bianca Nogrady
“I think the data are suggesting that it’s certainly in part due to the reduction in LDL — that is very important — but it’s also due to other factors beyond changes in LDL,” Grinspoon said. He speculated that the statin could be affecting anti-inflammatory and immune pathways, and that this could account for some of the reduction in cardiovascular risk, but “those data are cooking, and they’re being analysed as we speak.”
Read the full article here.
